4
Changes in Ownership
Axsome Therapeutics, Inc. Filed Acc 0001104659-15-086780
Chief Medical Officer bought 1,000 shares at $9.03 ($9,026)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kaye Randall Chief Medical Officer | 2015-12-23 | Purchase | +1,000 | $9.03 | $9,026 | 6,022 | I |
| Open-market purchases · 1,000 sh · avg $9.03 · $9,026 | |||||||
Loading xslF345X03/a4.xml…